Interstitial pneumonitis and myelosuppression associated to mitomycin C urinary tract instillations: A case report

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Montserrat Rodriguez-ReyesDolors Soy-Muner

Abstract

Mitomycin C as a treatment for superficial bladder carcinomas and upper urinary tract tumours has been linked to local adverse events. Systemic toxicity has been documented for just a very few cases. This report presents a case of interstitial pneumonitis accompanied by myelosuppression in a 74-year-old patient after receiving the fifth administration of mitomycin C through a ureteral catheter as a treatment for left kidney pyelocaliceal urothelial carcinoma. Therefore, suspecting mitomycin C toxicity, urinary tract instillations were discontinued, and intravenous filgrastim and methylprednisolone were initiated. Currently, after five months since the last mitomycin C urinary tract instillation, the patient is still receiving filgrastim and corticosteroids. A moderate effort dyspnoea persists despite interstitial pulmonary infiltrates have presented a very important reduction. Pancytopenia has also persisted. Blood count and lung function monitoring would be appropriate in patients undergoing mitomycin C instillations, especially in those with established prior lung disease.

References

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T T MuhonenS O Pyrhönen
Aug 1, 1986·The Journal of Urology·T A ZeinH Kim
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Jan 1, 1980·Archives of Orthopaedic and Trauma Surgery·G Lénárt
Aug 1, 1996·The Journal of Urology·J A Martínez-PiñeiroL Martínez-Piñeiro
Aug 19, 1999·Clinical Pharmacokinetics·M S HighleyE A De Bruijn
Aug 24, 2006·Expert Review of Anticancer Therapy·Christian BolenzMaurice Stephan Michel
May 29, 2009·Annals of Surgical Oncology·Laura A LambertPaul F Mansfield
Sep 18, 2009·Actas urologicas españolas·José M Janeiro PaisMarcelino González Martín
Feb 5, 2010·Respiration; International Review of Thoracic Diseases·Hiroshi WadaNaoki Sakai

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
bronchoalveolar lavage
biopsy

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.